Any Cancer Can Be a 'Rare Cancer'.

CANCER treatment; ANTINEOPLASTIC agents; NON-small-cell lung carcinoma; INDIVIDUALIZED medicine; CLINICAL drug trials; GENETICS

The article discusses the concept of cancer rareness with regard to the situation in precision medicine where advanced molecular profiling-based classifications of cancers have evolved, with an example where lung cancer has subtypes like EGFR mutated, KRAS mutated or ALK gene rearrangement non-small cell lung cancer. Topics discussed include the need for specific drugs for treating specific types of cancers and the benefits of targeted clinical trials.